Avadel Pharmaceuticals Plc Revenue per Employee (AVDL), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Avadel Pharmaceuticals Plc  (NASDAQ: AVDL)
 

Avadel Pharmaceuticals Plc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 55.34% in the third quarter 2025, year on year to cumulative value of $249 million, Avadel Pharmaceuticals Plc's revenue per employee grew on a trailing twelve months basis to $ 1,615,338, this marks a new company high.
Within the Healthcare sector Employees of 63 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 455, from total ranking in previous quarter at 569. Avadel Pharmaceuticals Plc has 154 employees.


What is Sales per Employee Ratio?







AVDL Revenue per Employee (Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
Y / Y Revenue Change 55.34 % 66.43 % 94.83 % 635.64 % 3233.56 %
Sales per Employee (TTM) $ 1,615,338 1,436,136 1,260,506 1,096,364 806,857
AVDL's Total Ranking # 455 # 569 # 637 # 833 # 1093
Seq. Revenue Change 14.32 % 30.48 % 0.65 % 3.47 % 22.48 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 40
Healthcare Sector # 64
Overall Market # 455

Revenue per Employee Statistics
High Average Low
$ 1,615,338 $ 854,410 $ 285,864
(Sep 30 2025)   (Jun 30 2020)



Financial Statements
Avadel Pharmaceuticals Plc's Revenue MRQ $ 77 Millions Visit AVDL's Income Statement
Avadel Pharmaceuticals Plc's Revenues TTM $ 249 Millions Visit AVDL's aggregate revenue growth
What are AVDL's Sales? Visit AVDL's Sales by Segment




Other Ratios
Avadel Pharmaceuticals Plc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
AVDL's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for AVDL's Competitors
Revenue per Employee for AVDL's Suppliers
Revenue per Employee for AVDL's Customers

You may also want to know
AVDL's Sales Growth Rates AVDL's Pe Price to earnings ratio AVDL's Receivables Turnover Ratio AVDL's Stock Quote
AVDL's Net Income Growth Rates AVDL's Ps Price to Sales ratio AVDL's Sales per Employee AVDL's Asset Turnover Ratio
AVDL's Net Margin AVDL's Pb Price to Book ratio AVDL's Financial Strength Ratios AVDL's Dividend Payout Ratio
Date modified: 2026-09-08T15:11:34+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2025Number of Employees Sep 30 2025
Harmony Biosciences Holdings inc   2,814,805.46 $ 824.738  Million 293 
Amgen Inc   2,767,000.00 $ 35,971.000  Million 13,000 
Assertio Holdings inc   2,591,547.17 $ 137.352  Million 53 
Therapeuticsmd Inc   2,363,000.00 $ 2.363  Million
Innoviva Inc   2,296,477.99 $ 365.140  Million 159 
Vaxart Inc   2,280,061.54 $ 148.204  Million 65 
United Therapeutics Corporation  2,234,571.43 $ 3,128.400  Million 1,400 
Aurinia Pharmaceuticals Inc   2,076,625.00 $ 265.808  Million 128 
Indivior Pharmaceuticals Inc   2,068,000.00 $ 2,068.000  Million 1,000 
Exelixis Inc   1,994,959.02 $ 2,288.218  Million 1,147 
Prestige Consumer Healthcare Inc   1,947,314.04 $ 1,109.969  Million 570 
Elite Pharmaceuticals Inc   1,872,514.65 $ 121.713  Million 65 
Evoke Pharma Inc   1,803,081.50 $ 14.425  Million
Ptc Therapeutics inc   1,795,307.77 $ 1,779.150  Million 991 
Collegium Pharmaceutical Inc   1,786,827.42 $ 755.828  Million 423 
Gilead Sciences Inc   1,711,000.00 $ 29,087.000  Million 17,000 
Incyte Corporation  1,692,371.66 $ 4,813.105  Million 2,844 
Privia Health Group Inc   1,666,043.23 $ 2,042.569  Million 1,226 
Cytomx Therapeutics Inc   1,646,826.09 $ 113.631  Million 69 
Kiniksa Pharmaceuticals International Plc  1,633,806.01 $ 597.973  Million 366 
Anaptysbio Inc   1,629,490.38 $ 169.467  Million 104 
Spero Therapeutics Inc   1,621,960.00 $ 40.549  Million 25 
Rigel Pharmaceuticals Inc  1,621,126.44 $ 282.076  Million 174 
Avadel Pharmaceuticals Plc  1,615,337.66 $ 248.762  Million 154 
Eton Pharmaceuticals Inc   1,593,545.45 $ 70.116  Million 44 
Protagonist Therapeutics inc   1,584,977.27 $ 209.217  Million 132 
Progyny Inc   1,481,349.30 $ 1,268.035  Million 856 
Bristol myers Squibb Company  1,477,969.23 $ 48,034.000  Million 32,500 
Jazz Pharmaceuticals Plc  1,438,696.54 $ 4,157.833  Million 2,890 
Xenetic Biosciences Inc   1,429,467.50 $ 2.859  Million




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.